HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein
Authors:
- Shozo KoboriSKShozo Kobori
- Takeshi MatsumuraTMTakeshi Matsumura
- Takeshi BiwaTBTakeshi Biwa
- Yoshihiro SatoYSYoshihiro Sato
- Toru TakemuraTTToru Takemura
- Hideki HakamataHHHideki Hakamata
- Seikoh HoriuchiSHSeikoh Horiuchi
- Motoaki ShichiriMSMotoaki Shichiri
- 1 August 1997
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 133 (1) , 51-59
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 48 references indexed in Scilit:
- Two independent macrophage receptors for acetylated high-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Cross‐linking of apolipoproteins is involved in a loss of the ligand activity of high density lipoprotein upon Cu2+‐mediated oxidationFEBS Letters, 1992
- Effect of Lovastatin on Suppression and Regression of Atherosclerosis in Lipid-Fed RabbitsJournal of Cardiovascular Pharmacology, 1992
- Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in HumansThe Journal of Clinical Pharmacology, 1992
- Prevention of restenosis by lovastatin after successful coronary angioplastyAmerican Heart Journal, 1991
- Regulation of the mevalonate pathwayNature, 1990
- Beyond CholesterolNew England Journal of Medicine, 1989
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986